SIRT3 inhibition promotes age-associated vascular impairment by mediating mitochondrial dysfunction and endothelial-to-mesenchymal transition.

Ke S, Yang H, Lu W, Wu L, Zhang Y, Qian X, Chen Y.

Open source

DOI
10.1016/j.exger.2026.113250
Published
2026-07-25
Container
Exp Gerontol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.exger.2026.113250,
  title = {SIRT3 inhibition promotes age-associated vascular impairment by mediating mitochondrial dysfunction and endothelial-to-mesenchymal transition.},
  author = {Ke S and  Yang H and  Lu W and  Wu L and  Zhang Y and  Qian X and  Chen Y.},
  year = {2026},
  journal = {Exp Gerontol},
  doi = {10.1016/j.exger.2026.113250},
  url = {https://doi.org/10.1016/j.exger.2026.113250}
}

RIS

TY  - JOUR
TI  - SIRT3 inhibition promotes age-associated vascular impairment by mediating mitochondrial dysfunction and endothelial-to-mesenchymal transition.
AU  - Ke S
AU  -  Yang H
AU  -  Lu W
AU  -  Wu L
AU  -  Zhang Y
AU  -  Qian X
AU  -  Chen Y.
PY  - 2026
JO  - Exp Gerontol
DO  - 10.1016/j.exger.2026.113250
UR  - https://doi.org/10.1016/j.exger.2026.113250
ER  - 

APA

S, K., H, Y., W, L., L, W., Y, Z., X, Q., & Y., C. (2026). SIRT3 inhibition promotes age-associated vascular impairment by mediating mitochondrial dysfunction and endothelial-to-mesenchymal transition.. Exp Gerontol. https://doi.org/10.1016/j.exger.2026.113250

Source records